Implementation of the action plan (roadmap) "Improving availability of narcotic drugs and psychotropic substances for medical use", approved by Decree of the Government of the Russian Federation No. 1403-p of 01.0.2016, the prospects for the development of palliative care in the field of pain relief for patients in need of narcotic and psychotropic drugs in the Russian Federation. Social mission of Moscow Endocrine Plant
Most of the pain medication in the country is produced by the Moscow Endocrine Plant. This enterprise is a co-executor of the roadmap to increase the availability of narcotic drugs and psychotropic substances for medical use, adopted in 2016. In recent years, the company has significantly expanded the range of non-invasive narcotic analgesics used to provide palliative care to aduls and children. The article describes the measures taken by the state to ensure the estimated need for non-invasive narcotic analgesics of patients in the constituent entities of the Russian Federation. At the same time, there are a number of regions whose applications for these drugs are able to provide adequate pain relief to only half of those patients who need it.